|
| Exchange Disseminated Time 27/07/2016 14:52:34 | Jubilant Life Sciences Ltd has informed BSE that a meeting of the Board of Directors of the Company is scheduled to be held on Tuesday, August 09, 2016, inter alia, to consider Unaudited Financial Results of the Company for the quarter ended June 30, 2016 (Q1).
Further, as per the Company’s Code of Conduct for Prevention of Insider Trading, the Trading Window for dealing in the securities of the Company would remain closed for the Designated Persons of the Company from Tuesday, August 02, 2016 to Thursday, August 11, 2016 (both days inclusive). |
|
|